What is/are Cefoxitin?
Cefoxitin is a cephamycin antibiotic developed by Merck & Co., Inc., often grouped with the second−generation cephalosporins. It is sold under the brand name Mefoxin.
Cefoxitin acts by interfering with cell wall synthesis. Its activity spectrum includes a broad range of gram-negative and gram-positive bacteria including anaerobes. It is inactive in vitro to most strains of Pseudomonas aeruginosa and enterococci and many strains of Enterobacter cloacae. Staphylococci resistant to methicillin/oxacillin should be considered resistant to cefoxitin.
Cefoxitin is considered a strong beta-lactamase inhibitor, as are certain other antibiotics (such as imipenem).
This article uses material from the Wikipedia article Cefoxitin, which is released under the Creative Commons Attribution-Share-Alike License 3.0.